# ToxMCP Audit - Delivery Summary (Reviewed Copy)

**Package date:** 2026-04-15  
**Status:** Reviewed for internal consistency, evidentiary discipline, and delivery readiness

---

## What this package is

This is a **reviewed internal audit pack** for the ToxMCP ecosystem covering:

- `comptox-mcp`
- `oqt-mcp`
- `aop-mcp`
- `pbpk-mcp`

It is strong as:
- a red-team architecture review
- a remediation planning pack
- a leadership briefing artifact

It is **not yet** the same thing as:
- a third-party assurance report
- a submission-ready validation package
- a fully reproduced penetration or compliance test report

---

## What changed in the reviewed copy

The original package had strong insights but needed a more defensible presentation. This reviewed copy:

- distinguishes **observed facts** from **architecture inferences** and **scenario narratives**
- removes or softens overly absolute phrasing
- normalizes dates and terminology
- marks code snippets as **reference implementations**
- updates future-proofing language to current public MCP context
- adds a validation backlog for findings that need live-repo confirmation

See:
- `AUDIT_EVIDENCE_FRAMEWORK.md`
- `REVISION_LOG.md`
- `VALIDATION_BACKLOG.md`
- `PUBLIC_REFERENCE_NOTES.md`

---

## What is included

### Package-level docs
| File | Purpose |
|---|---|
| `README.md` | Entry point |
| `DELIVERY_SUMMARY.md` | This document |
| `INDEX.md` | Navigation by audience |
| `QUICK_REFERENCE.md` | Fast triage view |
| `TOXMCP_MASTER_AUDIT_REPORT.md` | Revised cross-suite synthesis |
| `AUDIT_EVIDENCE_FRAMEWORK.md` | Evidence/confidence/severity rules |
| `REVISION_LOG.md` | What changed in this reviewed copy |
| `VALIDATION_BACKLOG.md` | Follow-up tasks before external use |
| `PUBLIC_REFERENCE_NOTES.md` | Public protocol and regulatory context consulted during review |

### Specialist reports
- `toxmcp_regulatory_audit_report.md`
- `toxmcp_adversarial_audit_report.md`
- `toxmcp_contract_audit_report.md`
- `toxmcp_security_audit_report.md`
- `ToxMCP_Performance_Resilience_Audit_Report.md`
- `toxmcp_observability_audit_report.md`
- `cognitive_ergonomics_audit_report.md`
- `toxmcp_future_proofing_audit_report.md`

### Repository-specific packages
- `comptox-mcp-audit/`
- `oqt-mcp-audit/`
- `aop-mcp-audit/`
- `pbpk-mcp-audit/`

Each repository package includes:
- `README.md` — reviewed summary of findings and sequencing
- `REMEDIATION_CODE.md` — implementation-oriented reference code, not drop-in patches

### Shared reference code
- `toxmcp_remediation_snippets.py`

---

## Most important package-level conclusions

### 1. The strongest issues are architectural, not local
The pack is at its best when it identifies cross-cutting gaps such as:
- provenance and time-machine reconstruction
- cross-suite orchestration and contradiction handling
- mandatory scientific review checkpoints
- uncertainty propagation
- distributed tracing and replayability

### 2. Some original language was too absolute
The reviewed copy deliberately replaces phrases like:
- "FDA rejection"
- "submission rejection"
- "certain"
- "production-ready"

with wording that better matches the level of evidence actually shown.

### 3. The remediation code should be read as design guidance
Several code blocks are valuable patterns, but they still require:
- repository-specific adaptation
- test coverage
- dependency and runtime checks
- review by domain owners

---

## Recommended reading order

### Leadership / program owner
1. `TOXMCP_MASTER_AUDIT_REPORT.md`
2. `QUICK_REFERENCE.md`
3. `VALIDATION_BACKLOG.md`

### Engineering leads
1. `INDEX.md`
2. repository `README.md` files
3. relevant specialist report(s)
4. relevant `REMEDIATION_CODE.md`

### Security / quality / regulatory reviewers
1. `AUDIT_EVIDENCE_FRAMEWORK.md`
2. `toxmcp_security_audit_report.md` or `toxmcp_regulatory_audit_report.md`
3. `VALIDATION_BACKLOG.md`

---

## Package posture after review

| Use case | Fit |
|---|---|
| Internal planning and prioritization | **Strong** |
| Engineering remediation sequencing | **Strong** |
| Leadership briefing | **Strong** |
| External diligence without further validation | **Limited** |
| Formal compliance or security attestation | **Not yet** |

---

## Immediate next step

Use this reviewed copy to align on priorities, then execute the validation tasks in `VALIDATION_BACKLOG.md` against the live repositories before sending the package outside the team.
